The U.S. Food and Drug Administration (FDA) has issued a letter reminding developers and manufacturers of new plant varieties intending to transfer genes for proteins that are food allergens into new plant varieties used for food of the relevant legal requirements for such products.
Part of Food Safety Magazine’s series with the U.S. Food and Drug Administration (FDA), titled, “Evolution of a New Era: Advancing Strategies for Smarter Food Safety,” this episode of Food Safety Matters discusses the research and application of behavior sciences with retail foodservice employees and regulatory agencies that help reduce foodborne illness risk factors.
Of all the key features of FDA's Traceability Final Rule, the Traceability Lot Code (TLC) stands out for its criticality and understated complexity. This crucial code serves as a breadcrumb trail, highlighting every step a product takes through the supply chain.To meet the TLC requirements, industry actors will need to make significant modifications to current lot coding practices.
In this episode of Food Safety Matters, we talk with Donald A. Prater, D.V.M., the Acting Director of the Office of Food Policy and Response (OFPR) at the U.S. Food and Drug Administration and the Associate Commissioner for Imported Food Safety at OFPR. Dr. Prater discusses the work he has overseen regarding import food safety, particularly for fresh produce and seafood; food safety culture; and smarter tools and technologies for data-gathering and data-sharing.
The U.S. Food and Drug Administration (FDA) has revised the guidance, titled, Labeling of Certain Beers Subject to the Labeling Jurisdiction of FDA, as well as two other guidances, to add “sesame” to the list of major food allergens for labeling purposes.
The Alliance to Stop Foodborne Illness and FDA are co-hosting a highly anticipated food safety culture webinar live from the Food Safety Summit on Thursday, May 11. During the live session, academic, regulatory, and industry professionals will discuss how they assess food safety culture and its impact.
The U.S. Food and Drug Administration (FDA) has provided an update on its partnership with Mexico’s National Service of Agro-Alimentary Health, Safety, and Quality (SENASICA) and the Mexican Federal Commission for Protection against Sanitary Risk (COFEPRIS).
In a letter distributed by the U.S. Food and Drug Administration’s Center for Food Safety and Applied Nutrition (FDA’s CFSAN) to FDA staff, CFSAN Director Susan T. Mayne, Ph.D. announced that she will be stepping down from her position on May 31, 2023.
On March 8, 2023, the U.S. Food and Drug Administration (FDA) released an Immediate National Strategy to Increase the Resiliency of the U.S. Infant Formula Market. On the same day, the agency’s response to the recent infant formula safety and supply crisis was called into question during a hearing with the U.S. House of Representatives Subcommittee on Health Care and Financial Services Hearing.
The U.S. Food and Drug Administration (FDA) has completed its second premarket consultation for a food made from cultured animal cells intended for human consumption. FDA evaluated the information submitted by GOOD Meat Inc. and has no further questions at this time about the company’s safety conclusion.
